Sickle Cell Disease news and research updates
Research readouts, treatment and access decisions, and community updates for people living with sickle cell disease and the people who care for them — each one dated, with a link to the original source where there is one.
436 articlesFree, no login required
Looking for earlier coverage? Browse the news archive.
FDA Expands Use of First Sickle Cell Disease Gene Therapy for Children as Young as 2 Years
WEDNESDAY, July 8, 2026 (HealthDay News) -- The U.S. Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients aged 2…
How a CRISPR Gene Therapy Could Change Life for Young Children With Sickle Cell Disease
In a recent announcement, the U.S. Food and Drug Administration (FDA) approved the first gene therapy for children aged 2 years and older with sickle cell disease. This inherited…
Over 650 Suspected Sickle Cell Anemia Cases Found in Dang
Dang. More than six hundred and fifty suspected sickle cell anemia patients have been found when more than five thousand citizens were tested for sickle cell anemia and…
Hydroxyurea Monotherapy Insufficient to Treat Chronic Anemia in SCD
Hydroxyurea monotherapy is insufficient to treat chronic anemia in sickle cell disease (SCD) ; rather, a combination therapy approach is likely to yield more clinical benefits…
Nanotechnology-Based Detection of Sickle Cell Disease and Thalassemia: A Systematic Review
Abstract Sickle cell disease (SCD) and thalassemia are genetic disorders that necessitate accurate diagnosis for effective management and improved patient outcomes. The advent of…
FDA Grants Priority Review to Agios’ Mitapivat sNDA for Sickle Cell Disease
The US Food and Drug Administration (FDA) has accepted Agios Pharmaceuticals, Inc.’s supplemental New Drug Application (sNDA) for mitapivat in sickle cell disease (SCD) and…
Global Sickle Cell Anemia Testing Market to Reach $1.63 Billion by 2034, Driven by Newborn Screening and Molecular Diagnostics
The Sickle Cell Anemia Testing and Screening Market offers growth opportunities through expanded newborn testing, molecular diagnostics, and digital workflows. Companies must…
Uganda pushes for early sickle cell screening as new treatment hope emerges
Ugandans have been urged to know their sickle cell status and embrace early screening as the country strengthens efforts to combat sickle cell disease, one of the most common…
Pain, Stigma and Silence: The hidden survival gap in sickle cell anaemia
In developed countries, many people living with sickle cell disease routinely celebrate their 50th, 60th birthdays and beyond, enjoying good quality of life thanks to…
Mitapivat for Sickle Cell Disease Earns FDA Priority Review
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for mitapivat in sickle cell disease (SCD). Mitapivat is an…
U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease
CAMBRIDGE, Mass. , July 07, 2026 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative…
Gene Therapy Casgevy Approved for Younger SCD and TDT Patients
The Food and Drug Administration (FDA) has expanded the approval of Casgevy ® (exagamglogene autotemcel) to include patients aged 2 years and older with either sickle cell disease…